TABLE 1.
HPV-16 DNA, HPV-16 E6 and E7 CTL, and HPV-16 VLP IgG antibody results for four subjects with a single period of HPV-16 DNA detection
| Subject | Duration of HPV-16 DNA detection (mo) | Presence or absence of CTL or Aba
|
|||
|---|---|---|---|---|---|
| During HPV-16 DNA detection period
|
After clearance of HPV-16 infectionb
|
||||
| CTL (E6/E7) | VLP Ab | CTL (E6/E7) | VLP Ab | ||
| 1 | 65 | − | + | + | + |
| 2 | 37 | + | + | + | + |
| 3 | 10 | NAc | − | + | − |
| 4 | 17 | NA | NA | + | + |
a
Ab, antibody.
b
Data cover the 20 months following the period of HPV-16 detection.
c
NA, analysis not initiated during the corresponding period of detection.